₦airaland Forum

this one na siamese snake

Over 3,216 Nigerians Sign Petition Asking
Varsity to Withdraw Okonji-Iweala’s
Doctorate

As at press time on Friday, about 3,216
persons had signed a petition asking Yale
University to withdraw the honorary doctorate
degree awarded to Nigeria’s Coordinating
Minister of the Economy and Finance Minister,
Dr. Ngozi Okonjo-Iweala.
Okonjo-Iweala had been awarded a Doctorate
of Humane Letters on Monday, May 18, 2015
during Yale’s Commencement ceremony in New
Haven, Connecticut, alongside eight others.
The petition, which is being hosted on
change.org , the world’s largest petition
platform, was started by a Nigerian resident in
the United States, one Sunday Iwalaiye.
When THISDAY visited the web page, it was
discovered that 1,784 more petitions were
needed to reach 5,000, which will probably
prompt the organisation to consider the
petition worthy of consideration.
When the petitioner kicked off the movement,
the signatures had trickled in by the seconds
but they have since leaped to over 3,000, with
more probably on the way.
Tagged “Yale University gave its prestigious
honorary doctorate degree to an undeserving
Nigerian,” the petition reads in part: “There is
no tangible evidence of any economic
development in Nigeria under the leadership of
Ngozi Okonjo-Iweala (sic) in all reality.
“Nigeria’s economy is still an oil-dependent
economy that is debt and borrowing ridden as
well as 100% consuming and importing in
nature.”

(curled from the internet)

you will find the solution on this thread. it has been asked severally.

www.nairaland.com/1921049/solve-maths-win-200-network

A good selfie takes a lot of work, usually a
series of well-angled snaps are taken before
the right one is posted all over social media.
The trick to a great selfie is good lighting, a
great a filter and most importantly, capturing
your best side. And the right angle means
exploring your environment.
Unfortunately, most people are now willing to
go to great lengths to take the perfect snap,
even putting their lives in jeopardy.
I have laughed about several selfie trends that
are making waves, but this is honestly
ridiculous, people are risking their lives in the
name of social media.
Just a year ago Kim Kardashian was almost
trampled to death by an elephant while
snapping a selfie!

Here’s a look at five tragic selfie inflicted
accidents:


1.
Sylvia Rajchel

While taking a break from medical school in
Spain, a Polish student lost her footing
attempting to take a selfie on the ledge of the
Puente de Trianna Bridge in Seville. The 23-
year-old stumbled and landed on the bridge’s
concrete support system after falling a
shocking 15 feet! I can’t even imagine the fear
of watching yourself fall to your near death.


2.
Anna Ursu (and her recovering friend)

Two Romanian teenagers planned to take the
selfie of all selfies, i.e. on top of a train. This
is popular in Instagram culture. Anna’s foot
allegedly touched a live wire sent 27 000 volts
through her body.
A man who reportedly saw them, before the
incident, attempted to put the flames out. The
18-year-old died having burned her entire
body while her friend later recovered at the St
Maria hospital.


3.
Iranian car-jamming girls

Two friends decided it would make for plenty
of likes and shares to post a karaoke video of
themselves whilst driving. The video quickly
went viral because the duo was involved in an
accident while jamming to an Iranian pop song
called “Ghorboni.” At one point the driver has
her eyes off the road and her hands were too
busy making hearts.
Surely if you can’t text and drive, then
definitely don’t Insta-vid and drive.
View on YouTube.


4.
Christine Rosello

A Rizal High School student in Manila,
Philippines fell down a flight of stairs, nine
steps from the third floor to the second, while
posing for a selfie with an energy drink.
Christine was only 13 when she died at the
Rizal Medical Center.


5.
Isabella Fracchiolla

During a field trip to Taranto, a city in Apulia,
Southern Italy, a 16-year-old student fell 18
meters onto jagged rocks while trying to take a
very risky selfie. Isabella suffered a series of
injuries and doctors were unable to save her
life.

this my brother strong o. e no even go small agencies. na big big fish he wan catch

*166# to migrate to club ten

ghostofsparta:
I don't feel offended by the film nor the director but sometimes feel upset by Abrahamist negro converts like you who can't see what's wrong with such production and how books such as The Jewish Phenomenon is a propaganda from an African POV.

now its obvious who you are. The bible is at your disposal. I'm not saying all accounts in the movie are correct, but its still on point. Read the book of exodus again.

OduaVanguard:
You are just a hater, pure and simple. Shey no be people dey work for there? At least give the state government credit for creating jobs through the initiative, considering that the state is largely a civil servant state. Smh.

abeg. never quote me if you don't av a point. do you know how much and even if those pple working there are paid? I guess not. I av friends among them paid peanuts. Good innovation. that's right. but learn to do the right thing and at the right time.
after they launch their phones, tell me how many Nigerian ll patronize them. when better and cheaper ones full market

lets all say no to jungle justice and allow the law take its course

hmmm. a part of me likes the way they got their punishment after killing the business man but another sympathizes for our nation. we have to let law take its course and not take it into our hands. see as crowd gather and not even one person stop the act. An eye for an eye is not always the solution to problems. someone could be innocent and yet killed for an unknown offence

This level of unemployment for Nigeria don gbege o. nawa for you o. op

where are the pictures

payback time is not always the sweetest. but I'm enjoying this one o

well. its not as if all the stories documented in the movie are true. yet the message there is obvious and as a Christian, I know my they are. Op definitely is not a Christian. sorry if you feel offended by the movie.

shey na those local phones we wan chop. Abeg, make the ogbeni pay Money and stop wasting resources on frivolities. Different phones wey correct and even cheap plenty for market. I wonder what this so called innovations are about. All their opon imos etc are no more working.

We often call footballers overpaid bunch of
divas playing the game, they love the most.
But when we talk about why the footballers are
getting paid so much than we have to Consider
the fact that it depends on the demand and
supply in the european football industry. Its a
multibillion industry which is growing at a very
fast rate. Cristiano Ronaldo is by far the
highest paid played in the world and he
doubles his yearly income with many high
profile endorsement deals. But how much the
footballers have to pay the tax ? Well for that
we have to look different league and we will
take the example of £200,000-a-week salary in
every league to see in which league what tax
footballers are paying.
ENGLAND
INFORMATION
DETAILS
Top League
Premier League
Example Salary
£200,000-a-week
Tax Rate
45%
After tax Salary
£106,206-a-week
Average EPL Salary
£30,000-a-week
Players Like Wayne Rooney, Yaya Toure, Sergio
Aguero, Robin Van Persie are getting paid in
the access of £200,000-a-week salary which
means their weekly earnings after tax comes
down to half of the actual salary. Which means
a footballer on the wages of around £200,000-
a-week is annualy paying more than £6 million
just in taxes.
———————————————————————
——————————————————
SPAIN
INFORMATION
DETAILS
Top League
Spanish Primera Liga
Example Salary
£200,000-a-week
Tax Rate
52%
After tax Salary
£96,000-a-week
Average La Liga Salary
£22,000-a-week
In Spain the top tax rate is 52% and that was
the reason why Ronaldo wanted a new contract
with Real Madrid last season, now he is on
weekly salary of £288,000-after tax which
means Real Madrid have to pay around
£600,000-a-week to have Ronaldo in their
squad.
———————————————————————
——————————————————
GERMANY
INFORMATION
DETAILS
Top League
Bundesliga
Example Salary
£200,000-a-week
Tax Rate
47.475%
After tax Salary
£105,050 a-week
Average Bundesliga Salary
£20,000 a-week
———————————————————————
——————————————————
ITALY
INFORMATION
DETAILS
Top League
Italian Serie A
Example Salary
£200,000-a-week
Tax Rate
46.29%
After tax Salary
£107,420-a-week
Average Serie A Salary
£17,000-a-week
———————————————————————
——————————————————
RUSSIA
INFORMATION
DETAILS
Top League
Russia Premier League
Example Salary
£200,000-a-week
Tax Rate
13%
After tax Salary
£174,000-a-week
Average RPL Salary
£10,000 a-week
———————————————————————
——————————————————
FRANCE
INFORMATION
DETAILS
Top League
French Ligue 1
Example Salary
£200,000-a-week
Tax Rate
45%
After tax Salary
£110,000-a-week
Average Ligue 1 Salary
£14,000 a-week


curled from the internet

Please. Kindly help supply the answer to this question.
A client wants his bungalow painted as follows:
I. Balcony - Green
II. Sitting Room - Blue
III. Living Room - Cream
What would you suggest the color of the staircase to be?

Chai. people can lie ..eh

hmmm. nawa o.

To check ur balance dial *123*133#

He messed up

He ll simply close the lappy na. why damage it. maybe na Oyedepo grand child. money dey. but porn na sin

I only hope they ll deduct the mb normally as they would on other paid plans

Just text Join and send to 141. Its free. dial *123*133# to check ur balance

A few weeks ago, I watched the compelling documentary “Fire in the Blood,” an account of how Western pharmaceutical companies thwarted access of potentially life-saving AIDS drugs in Africa and the opposing grassroots effort to bypass these obstacles. I will summarize the key issues addressed in this controversial story, which also apply to the larger context of medical access in the developing world, and the roles of Western nations in global health. This article will serve as a jumping-off point for future articles, where I will explore further some of the issues that are raised. With this article, I will try to demonstrate the problem, but you will have to stay tuned to hear about possible solutions.

Most people are aware that in the past twenty years, AIDS went from a death sentence to a chronic, but treatable disease, thanks to antiretroviral (ARV) drugs. According to the World Health Organization (WHO), by the end of 2012, 9.7 million people worldwide were on ARV treatment, with 7.5 million of those people living in Africa.1 Everyone hears about the AIDS epidemic in Africa, but we’ve also heard about the tremendous progress that has been made in recent years getting people on ARVs and working to prevent the spread of HIV. Logically, most people assume that upon the development of ARVs, the number of deaths worldwide due to AIDS began to decline, which is in fact the case in the United States.

In the US, the number of deaths due to AIDS-related complications reached an all-time high in 1995, which was the same year that clinical trials for ARVs were initiated and then approved as standard treatment by the FDA in 1996.2 In Africa, the numbers look rather different. A special report by UNAIDS states that AIDS-related deaths in Africa only began to decline in the year 2007.3 Why the gap? Why did AIDS deaths in the US begin to decline immediately after the development of ARVs, while AIDS deaths in Africa took over ten years longer? Millions of people in Africa died during the time between when ARVs came to market and when people in Africa had access to them. Many of those deaths could have been prevented if people had had access to ARVs. Why didn’t they?

I think to most people the answer is obvious. The drugs were too expensive. The price of brand named ARVs at the time was $10,000 USD per person per year.7 This price was completely unaffordable to most people in Africa, where the market for ARVs consisted of just 1% of the pharmaceutical industry’s total revenues. Africans themselves could not afford the medicine, and groups like Doctors without Borders and others could not afford to treat their patients in Africa.

Why are ARVs so expensive? Most people attribute high prices of drugs to the fact that drug companies have to recoup their extremely high R& costs through sales. Thus, the current patent system is designed to give drug companies exclusive rights to sell their drug at their chosen price for twenty years in order to incentivize their investment in the development of new drugs, a process that takes many years and a lot of money. This is the system that we have.

This means that people in Africa couldn’t afford ARV treatment because the companies that owned patents on these drugs (such as Pfizer) were able to set prices as high as they needed to in order to recoup their investments. For people in the US, this is acceptable because our health insurance will cover the cost of the drug. In Africa, most people pay for their medicines out-of-pocket, so they simply could not afford ARVs.

While the drugs were out of reach in Africa, for people in other countries, such as Thailand, the drugs were more affordable because generic companies in Thailand were able to produce ARVs at a reduced price. Drug companies who held the patents for ARVs owned exclusive rights to the drugs in many countries in Africa, but not in other countries, such as Thailand. This was due to trade laws imposed on certain countries by the Trade Related Aspects of Intellectual Property (TRIPS) agreement set up by World Trade Organization (WTO).

Thus, these countries were able to manufacture the drugs at a much cheaper price so that it could be affordable to many more people. For reference, the cost of the patented medicine was $10,000 per patient per year, but the price of the generic, as manufactured by the Indian generic company Cipla, was $365 per patient per year, or $1 per day5. The Wikipedia article on HIV/AIDS in Africa includes this one-sentence blurb: “For African countries with advanced medical facilities, patents on many drugs have hindered the ability to make low cost alternatives.” 4

Because of the rights to exclusivity on ARVs, South Africa was not allowed to import cheaper generic drugs from India or Thailand to improve the prospects for their dying AIDS patients. But of course, as I mentioned before, the entire continent of Africa consisted of only about 1% of the pharmaceutical industry’s profits for ARVs. If they allowed countries in Africa to import generics, drug companies wouldn’t be losing profits anyway. So what was the problem?

Pharmaceutical companies were worried that allowing countries, such as South Africa, to import generic drugs would set a precedent, encouraging governments in other countries, where huge profits were already being made, including the United States, to try to do the same. Also, the African governments were afraid to side-step the patents and import generic drugs because they feared retaliation, such as trade sanctions, from international trade organizations like the WTO, which were dominated by western countries.

The people in South Africa were not keeping quiet about their lack of access to ARVs. With so many people dying around them, South Africans were taking a stand and actively protesting patents on ARVs, appealing to Western governments to allow the importation of generics to South Africa. In 1998, the Treatment Action Campaign was founded by activist Zachie Achmat to fight for access to generic ARVs.6 Achmat, himself, refused to take his own ARVs until everyone in his country had access to them. Unfortunately, few in the Western world heard the voices of South African activists like Achmat. Eventually, some journalists and US activists began to pay attention to the fight for generics in South Africa and helped appeal to Western governments for access.

It was a long fight. Eventually, the South African government began importing generic drugs into Africa without protest from Western countries or the WTO. More and more countries realized they would be able to import the generics without retaliation, so the generic drugs flooded into Africa and AIDS-related deaths declined.

Of course there are many other factors that affect access to medicines in developing countries, one of which is lack of healthcare infrastructure and lack of healthcare workers. However, in African countries between 1995 to the early 2000s, millions of people died from AIDS-related complications, and many of these deaths could have been prevented if people had been able to afford ARVs.

Pharmaceutical companies blocked access to lifesaving drugs for millions of people because they were afraid that allowing Africans to import generics would set a precedent that would ultimately diminish their own profits. This was only overcome after years and years of hard work by activists, journalists and many others coming together to put pressure on Washington DC and other western governments to allow importation of generics. Finally, Western countries turned a blind eye when South Africa began importing the generic ARVs, but this would not have happened if it were not for the intense amount of political pressure and criticism that they were facing.

Although African countries are now able to import generic ARVs, the problems of affordability and accessibility are far from over. Many other patented drugs remain out of reach for people in developing countries. Also, with NCDs (non-communicable diseases) on the rise worldwide, access to these medicines, such as cancer drugs, is becoming more and more of a problem.

So there you have it. Patents give drug companies exclusive rights to sell their drugs for twenty years, making them unaffordable for so many people in low and middle-income countries. However, without patents, drug companies would have no incentives to develop drugs in the first place. This system is clearly flawed but not so easily amended. I will try to present some alternatives to this system in forthcoming blog posts.

Before concluding, we must keep in mind the fact that a substantial amount of the money that goes into funding R& for new drugs is public money. And much of the basic research for new drugs is conducted at universities like ours, with funding from the NIH and other government organizations. So what does this mean for the products and services that result from publicly funded research and drug discovery? Are the pharmaceutical companies the only ones who have a stake?

curled from https://theejbm./2013/10/01/the-untold-aids-story-how-access-to-antiretroviral-drugs-was-obstructed-in-africa/

Count down. First, it starts this weekend. Their so called useless party ll be crushed this weekend. They want to mortgape the future of nigeria and God wil not allow them. Clueless apc. We osun pple are going to vote em out this time around